GH Research PLC 6-K filed 2026-09-11

GH Research PLC filed a Form 6-K on 2026-09-11. The cover page identifies it as a "Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934" for the month of September, 2026, under Commission File Number 001-40530. The company checked the box saying it files annual reports under cover of Form 20-F. It gives its principal executive office as Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland. The filing makes one disclosure. GH Research PLC will hold one-on-one investor meetings during the Morgan Stanley 24th Annual Global Healthcare Conference, which is scheduled for September 14 – 16, 2026, in New York. Magnus Halle, Company Secretary, signed the report on September 11, 2026. For an analyst or journalist, the filing tells you the company plans private meetings with investors at this conference. It does not say who the company will meet, what it will discuss, or whether it will present publicly or webcast anything. None of that is in the filing. The excerpt also contains no financial figures, clinical or product updates, or guidance. EDGAR lists the company under CIK 1855129 with SIC code 2834, Pharmaceutical Preparations. It trades as GHRS on Nasdaq, and its filer category is "Accelerated filer" and "Emerging growth company," with a fiscal year end of 1231.